Reason for request
Re-assessment of the Actual Benefit
Clinical Benefit
| Insufficient |
The actual benefit of the proprietary medicinal product ROHYPNOL is insufficient in the treatment of "severe sleep disorders in the following cases: occasional insomnia, transient insomnia". |
Therapeutic use
eNq1mE1z2jAQhu/8Co8PvWHjED7S2mRamrTMJFNKwrTTCyPsJYgKydEHgf76ypg0pCM3qUBHW/a7K+3q0TuKz9dL4q2AC8xo4kdBw/eApizD9C7xx7eX9a5/3qvFC7RCe591gkYQnfheSpAQiV+MBlNAVATfr68+gv4fuN+reTGbLiCVz75TEpPgMxLza5QX33jxiuHMW4KcsyzxcyW3b71YSK6z6D0w/lPkKIU43L3ZH11MTvffx2Eh9gpVJYBfIXpnFAVqpZkqzoHKPpJwx/imIt+mlTYWIxBM8RSGSM6HnK1wBpkxxAwRAVZBZg/ZDfAVAVkEMYqHi3QprMTRAq1HcD8wJ/1ej/blWtYb9ajTaZ02Wp2TqNloW4Xie0tlroKeRJhOok6rHXXbIdCQs/kmp4xYFmfIuETEUVmw6D/vLEdxONy/WP4Mi5ygTbAQue1SIY70MHC9/91NpJjBLddEInrN/tKnipDwP7Me73jhKOMCR32mqKzAxuXIdiH6jEpYV1fUjnRyvetFDOJ4sr8YNVN+qKYEp7ZM09RRIOR4NKhG2lFp8AEJGHN3OPiGacYexPExs19WR9nnW1IaRXOeRZOTs247arWsd9EP3UMVZ8yF4iyHUAMIi0O4MqAzdihRdFuapR6b8nj9uLU6LEUEKsxO3ZIuuhEfvZmzVne3jcoBo+ini1vb/viqgG9uto9GaZwlfyprh14XPNfd+FLi5b5N8kmz0eqeNU/foGX+7tFFJ5aOuRR1YpgVN0NmLmUu3obhHIm6QHotgxn/xwlwbpz3MeaucftUSneG3sn5X/qhErWOUp+WZ+jra2i7Y19yB4c63t3/O2dtjCG5ggPqUMLdGYIHF8en+pPddZb28Blb3IXZWlMkMaOuHJOaGhUPO0d0Xekl13D4MpvhisuVyr6Mw/Jip1eLw+JSp1f7DXp8/3k=
VAsRT6KUqCqFJTMU
